Galectin Therapeutics reported $-0.2 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Gilead Sciences USD 2.03 0.17 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Merck USD -1.28 3.32 Mar/2026